RecallDepth
Class III Terminated

Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05), b) 500-count bottle (NDC 68001-264-03) , Rx only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India For BluePoint Laboratories

This recall has been terminated (originally issued November 23, 2016).

Company
Amerisource Health Services
Recall Initiated
October 27, 2016
Posted
November 23, 2016
Recall Number
D-0137-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 15,409 bottles b) 5,128 bottles
Firm Location
Columbus, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: The firm was notified that there was a dissolution out of specification result on the 6 month stability samples.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: a) M601509, Exp 3/31/2018; M606506, Exp 4/30/2018; b) M601510, Exp 3/31/2018; M604444, Exp 4/30/2018; M606515, Exp 4/30/2018.

More recalls by Amerisource Health Services

View all recalls by this company →

Other recent Class III Drug recalls